Literature DB >> 25223893

The artificial cycle method improves the pregnancy outcome in frozen-thawed embryo transfer: a retrospective cohort study.

Yu Zheng1, Xiyuan Dong, Bo Huang, Hanwang Zhang, Jihui Ai.   

Abstract

The aim of this retrospective cohort study was to investigate which preparation method is optimal for frozen-thawed embryo transfer (FET) treatment. Analyses were performed on 3160 FET cycles, including 654 cycles with a natural cycle (NC) protocol and 2506 cycles with an artificial cycle (AC) protocol. The primary outcome measures were the clinical pregnancy rate (CPR) and the live birth rate (LBR) per transfer. The Student's t-test, chi-square test and multiple logistic regression were used for statistical analysis. The CPR per transfer was 49.4% in the NC group and 58.6% in the AC group (OR = 1.270, 95% CI: 1.037-1.554). The LBR per transfer was 42.2% and 50.8% in the NC and AC groups, respectively (OR = 1.269, 95% CI: 1.037-1.552). Dividing the patients according to the type of transferred embryos, the CPR (67.3% versus 57.0%, p < 0.01) and LBR (58.8% versus 49.7%, p < 0.01) were higher after the AC protocol than after NC protocol in patients with blastocyst transfer. The NC and AC protocols yielded comparable CPR and LBR in the patients with cleavage embryo transfer. Our data indicate better pregnancy outcomes after the AC protocol than after the NC protocol. The AC protocol should be recommended in patients who were counseled before receiving FET treatment. Further studies are needed to confirm this finding.

Entities:  

Keywords:  Artificial cycle; frozen–thawed embryo transfer; live birth; natural cycle; pregnancy

Mesh:

Year:  2014        PMID: 25223893     DOI: 10.3109/09513590.2014.958988

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

1.  MicroRNA-223-3p suppresses leukemia inhibitory factor expression and pinopodes formation during embryo implantation in mice.

Authors:  Xiyuan Dong; Cong Sui; Kai Huang; Lan Wang; Dan Hu; Ting Xiong; Rui Wang; Hanwang Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Propensity score-matched study and meta-analysis of cumulative outcomes of day 2/3 versus day 5/6 embryo transfers.

Authors:  Ye Yin; Ge Chen; Kezhen Li; Qiuyue Liao; Sijia Zhang; Nieying Ma; Jing Chen; Yan Zhang; Jihui Ai
Journal:  Front Med       Date:  2017-07-25       Impact factor: 4.592

3.  Natural cycle versus artificial cycle in frozen-thawed embryo transfer: A randomized prospective trial.

Authors:  Marzieh Agha-Hosseini; Leila Hashemi; Ashraf Aleyasin; Marzieh Ghasemi; Fatemeh Sarvi; Maryam Shabani Nashtaei; Mahshad Khodarahmian
Journal:  Turk J Obstet Gynecol       Date:  2018-03-29

4.  Pregnancy rates from natural and artificial cycles of women submitted to frozen embryo transfers: a metanalysis.

Authors:  Karine Queiroz Poletto; Mayana de Pina Lobo; Melissa Giovanucci; Mário Silva Approbato; Eduardo Camelo de Castro
Journal:  JBRA Assist Reprod       Date:  2019-08-22

5.  The Morphology of Inner Cell Mass Is the Strongest Predictor of Live Birth After a Frozen-Thawed Single Embryo Transfer.

Authors:  Jihui Ai; Lei Jin; Yu Zheng; Peiwen Yang; Bo Huang; Xiyuan Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 5.555

6.  Endometrial preparation methods prior to frozen embryo transfer: A retrospective cohort study comparing true natural cycle, modified natural cycle and artificial cycle.

Authors:  Lena Mensing; Emilie S Dahlberg; Bjørn Bay; Anette Gabrielsen; Ulla B Knudsen
Journal:  Arch Gynecol Obstet       Date:  2022-01-30       Impact factor: 2.493

7.  Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.

Authors:  Chyi-Uei Chern; Kuan-Hao Tsui; Salvatore Giovanni Vitale; San-Nung Chen; Peng-Hui Wang; Antonio Cianci; Hsiao-Wen Tsai; Zhi-Hong Wen; Li-Te Lin
Journal:  Reprod Biol Endocrinol       Date:  2018-09-17       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.